Sarepta Therapeutics, Inc. SRPT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s total current assets?
- Sarepta Therapeutics, Inc. (SRPT) reported total current assets of $2.31B in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s total current assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s total current assets decreased by 5.0% year-over-year, from $2.43B to $2.31B.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total current assets has grown at a 0.4% compound annual growth rate (CAGR), from $2.49B to $2.54B.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.